Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lowering cholesterol in old age.

M F Oliver1

  • 1National Heart and Lung Institute, Imperial College School of Science, Technology and Medicine, London.

Journal of the Royal College of Physicians of London
|July 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Place of the Coronary Care Unit.

Journal of the Royal College of Physicians of London·2019
Same author

Wondering….

The journal of the Royal College of Physicians of Edinburgh·2014
Same author

Free fatty acids and acute coronary syndromes--the history.

QJM : monthly journal of the Association of Physicians·2011
Same author

Cholesterol-lowering and cancer in the prevention of cardiovascular disease.

QJM : monthly journal of the Association of Physicians·2010
Same author

Sudden cardiac death: the lost fatty acid hypothesis.

QJM : monthly journal of the Association of Physicians·2006
Same author

Sudden unexpected cardiac death.

European heart journal·2002

Lowering cholesterol in older adults requires a conservative approach. Evidence for benefits is lacking, and treatment decisions should prioritize individual clinical judgment and patient well-being.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Plasma cholesterol levels naturally decline with age.
  • The association between cholesterol and vascular disease diminishes in advanced age.

Purpose of the Study:

  • To advocate for a conservative stance on cholesterol-lowering interventions in the elderly.
  • To evaluate the evidence supporting lipid-lowering treatments in older populations.

Main Methods:

  • Review of existing literature on cholesterol, aging, and vascular disease.
  • Analysis of data regarding the efficacy and risks of lipid-lowering drugs in the elderly.

Main Results:

  • Spontaneous decrease in plasma cholesterol concentrations observed with aging.

Related Experiment Videos

  • Weakening of the correlation between cholesterol levels and vascular disease in older individuals.
  • Lack of robust data demonstrating clear benefits of cholesterol reduction in the elderly.

    • Conclusions:

    • A cautious approach is recommended for lowering plasma cholesterol in advanced age.
    • Continued lipid-lowering treatment beyond age 75 for patients with coronary heart disease may be considered, based on clinical judgment.
    • Conflicting priorities, including treatment costs, influence therapeutic decisions in elderly care.